bioventus
-
Financial
Bioventus Reports Second Quarter Financial Results
Q2 Revenue Advanced by 10.3%, Organic Growth* by 13.9% Q2 Gross Margin Expanded 350 bps and Adjusted Gross Margin* 180 bps Cash…
Read More » -
Biologics
Bioventus Agrees to Nationwide Contract with Aetna™ Medicare Advantage Plans for DUROLANE® for Knee Osteoarthritis
DURHAM, N.C., Dec. 06, 2023 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for…
Read More » -
Biologics
LifeNet Health acquires best-in-class wound care portfolio
The acquisition of Bioventus Inc.’s wound care division includes all its dedicated professionals VIRGINIA BEACH, Va., May 10, 2023 /PRNewswire/ — LifeNet…
Read More » -
Top Stories
Bioventus Announces CEO Leadership Change
DURHAM, N.C., April 06, 2023 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for…
Read More » -
Financial
Bioventus Completes CartiHeal Acquisition
DURHAM, N.C., July 12, 2022 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for…
Read More » -
Financial
Bioventus Amends CartiHeal Acquisition Structure
DURHAM, N.C., June 21, 2022 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for…
Read More » -
Financial
Bioventus Exercises Call Option to Acquire CartiHeal
DURHAM, N.C., April 04, 2022 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for…
Read More » -
Financial
Bioventus Acquires Bioness, Inc.
DURHAM, N.C., March 30, 2021 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for…
Read More » -
Financial
Bioventus Inc. Reports Fourth Quarter and Full Year 2020 Financial Results; Introduces Full Year 2021 Financial Guidance
DURHAM, N.C., March 25, 2021 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in…
Read More » -
Biologics
Bioventus Receives Authorization to Proceed Under Investigational New Drug Application for Clinical Trial of Placental Tissue Particulate (PTP-001) for the Treatment of Knee OA
November 18, 2020 DURHAM, N.C.–(BUSINESS WIRE)–Bioventus, a leader in Solutions For Innovative Healing, received authorization to proceed under its investigational…
Read More » -
Biologics
Bioventus Appoints Chris Yamamoto Senior Vice President of Business Development and Strategy
November 16, 2020 DURHAM, N.C.–(BUSINESS WIRE)–Bioventus, a global leader in Innovations For Active Healing, has appointed Chris Yamamoto as Senior…
Read More » -
Biologics
Bioventus Reaches Milestone with 2 Million DUROLANE® Treatments Worldwide
September 22, 2020 DURHAM, N.C.–(BUSINESS WIRE)–Bioventus, a global leader in Innovations For Active Healing, is celebrating a milestone and recognizing…
Read More » -
Biologics
Bioventus Reports First Use of its SIGNAFUSE® Bioactive Bone Graft in Strip Format
September 2, 2020 DURHAM, N.C.–(BUSINESS WIRE)–Bioventus is sharing results of its first in-patient use of the new SIGNAFUSE Bioactive Bone Graft strips. Rick…
Read More » -
Biologics
Bioventus Appoints Katrina Church Chief Compliance Officer
August 24, 2020 Katrina Church, Chief Compliance Officer DURHAM, N.C.–(BUSINESS WIRE)–Bioventus, a global leader in orthobiologic solutions, has appointed Katrina…
Read More » -
Financial
Bioventus Makes $15 Million Equity Investment in CartiHeal with an Agreed Option Structure to Acquire Company Upon Milestone Achievements
July 16, 2020 KFAR SABA, Israel & DURHAM, N.C.–(BUSINESS WIRE)–CartiHeal, developer of the proprietary Agili™-C implant for the treatment of…
Read More »